Annual Total Expenses
$41.71 M
-$3.23 M-7.19%
31 December 2023
Summary:
Oncternal Therapeutics annual total expenses is currently $41.71 million, with the most recent change of -$3.23 million (-7.19%) on 31 December 2023. During the last 3 years, it has risen by +$24.17 million (+137.80%). ONCT annual total expenses is now -38.67% below its all-time high of $68.01 million, reached on 31 December 2008.ONCT Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$8.68 M
-$182.00 K-2.05%
30 September 2024
Summary:
Oncternal Therapeutics quarterly total expenses is currently $8.68 million, with the most recent change of -$182.00 thousand (-2.05%) on 30 September 2024. Over the past year, it has dropped by -$1.71 million (-16.45%). ONCT quarterly total expenses is now -52.78% below its all-time high of $18.38 million, reached on 31 March 2008.ONCT Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCT Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.2% | -16.4% |
| 3 y3 years | +137.8% | -9.9% |
| 5 y5 years | +6.8% | +75.4% |
ONCT Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.2% | +137.8% | -28.5% | +7.4% |
| 5 y | 5 years | -7.2% | +177.7% | -28.5% | +203.4% |
| alltime | all time | -38.7% | +4993.3% | -52.8% | +208.9% |
Oncternal Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.68 M(-2.1%) |
| June 2024 | - | $8.86 M(+1.0%) |
| Mar 2024 | - | $8.78 M(-8.9%) |
| Dec 2023 | $41.71 M(-7.2%) | $9.64 M(-7.3%) |
| Sept 2023 | - | $10.39 M(+8.9%) |
| June 2023 | - | $9.54 M(-21.4%) |
| Mar 2023 | - | $12.14 M(+1.9%) |
| Dec 2022 | $44.95 M(+43.3%) | $11.91 M(+5.2%) |
| Sept 2022 | - | $11.32 M(-4.0%) |
| June 2022 | - | $11.79 M(+19.0%) |
| Mar 2022 | - | $9.91 M(+22.7%) |
| Dec 2021 | $31.37 M(+78.8%) | $8.08 M(-16.2%) |
| Sept 2021 | - | $9.64 M(+25.3%) |
| June 2021 | - | $7.69 M(+29.0%) |
| Mar 2021 | - | $5.96 M(+108.3%) |
| Dec 2020 | $17.54 M(+16.8%) | $2.86 M(-34.9%) |
| Sept 2020 | - | $4.39 M(-20.6%) |
| June 2020 | - | $5.54 M(+16.5%) |
| Mar 2020 | - | $4.75 M(+13.6%) |
| Dec 2019 | $15.02 M(-61.5%) | $4.18 M(-15.5%) |
| Sept 2019 | - | $4.95 M(+40.1%) |
| June 2019 | - | $3.53 M(-40.5%) |
| Mar 2019 | - | $5.94 M(+6.4%) |
| Dec 2018 | $39.06 M(+27.4%) | $5.59 M(-42.0%) |
| Sept 2018 | - | $9.63 M(-5.2%) |
| June 2018 | - | $10.16 M(-25.8%) |
| Mar 2018 | - | $13.69 M(+45.6%) |
| Dec 2017 | $30.66 M(+18.2%) | $9.40 M(+10.2%) |
| Sept 2017 | - | $8.53 M(+32.4%) |
| June 2017 | - | $6.45 M(+2.6%) |
| Mar 2017 | - | $6.28 M(-8.5%) |
| Dec 2016 | $25.93 M(+18.7%) | $6.86 M(-0.9%) |
| Sept 2016 | - | $6.93 M(+14.4%) |
| June 2016 | - | $6.06 M(-0.5%) |
| Mar 2016 | - | $6.08 M(+2.1%) |
| Dec 2015 | $21.84 M(-28.0%) | $5.96 M(+1.6%) |
| Sept 2015 | - | $5.86 M(+18.2%) |
| June 2015 | - | $4.96 M(-1.9%) |
| Mar 2015 | - | $5.06 M(-7.3%) |
| Dec 2014 | $30.35 M(-30.4%) | $5.46 M(+10.1%) |
| Sept 2014 | - | $4.96 M(-54.7%) |
| June 2014 | - | $10.95 M(+21.8%) |
| Mar 2014 | - | $8.99 M(-2.1%) |
| Dec 2013 | $43.60 M | $9.18 M(+2.4%) |
| Sept 2013 | - | $8.96 M(-30.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2013 | - | $12.82 M(+1.5%) |
| Mar 2013 | - | $12.64 M(-2.1%) |
| Dec 2012 | $49.73 M(+13.1%) | $12.91 M(+1.1%) |
| Sept 2012 | - | $12.76 M(+9.7%) |
| June 2012 | - | $11.64 M(-6.3%) |
| Mar 2012 | - | $12.42 M(+3.5%) |
| Dec 2011 | $43.97 M(+5.5%) | $12.00 M(+10.2%) |
| Sept 2011 | - | $10.89 M(-11.7%) |
| June 2011 | - | $12.32 M(+1.1%) |
| Mar 2011 | - | $12.19 M(+119.0%) |
| Dec 2010 | $41.69 M(-32.1%) | $5.57 M(-43.6%) |
| Sept 2010 | - | $9.88 M(-29.1%) |
| June 2010 | - | $13.94 M(+13.2%) |
| Mar 2010 | - | $12.31 M(-15.8%) |
| Dec 2009 | $61.41 M(-9.7%) | $14.61 M(-11.3%) |
| Sept 2009 | - | $16.47 M(+8.6%) |
| June 2009 | - | $15.16 M(-0.1%) |
| Mar 2009 | - | $15.17 M(-11.5%) |
| Dec 2008 | $68.01 M(+29.2%) | $17.14 M(+10.3%) |
| Sept 2008 | - | $15.54 M(-8.3%) |
| June 2008 | - | $16.95 M(-7.8%) |
| Mar 2008 | - | $18.38 M(+16.4%) |
| Dec 2007 | $52.63 M(+14.4%) | $15.80 M(+19.6%) |
| Sept 2007 | - | $13.21 M(+6.6%) |
| June 2007 | - | $12.39 M(+10.3%) |
| Mar 2007 | - | $11.23 M(+9.5%) |
| Dec 2006 | $46.02 M(+8.7%) | $10.26 M(-18.6%) |
| Sept 2006 | - | $12.60 M(+11.4%) |
| June 2006 | - | $11.31 M(-4.7%) |
| Mar 2006 | - | $11.86 M(+29.8%) |
| Dec 2005 | $42.34 M(+68.3%) | $9.14 M(-16.2%) |
| Sept 2005 | - | $10.91 M(-10.6%) |
| June 2005 | - | $12.20 M(+20.9%) |
| Mar 2005 | - | $10.09 M(+33.8%) |
| Dec 2004 | $25.16 M(+75.5%) | $7.54 M(+30.6%) |
| Sept 2004 | - | $5.77 M(-0.9%) |
| June 2004 | - | $5.83 M(-3.3%) |
| Mar 2004 | - | $6.02 M(+30.6%) |
| Dec 2003 | $14.34 M(+19.3%) | $4.61 M(+34.2%) |
| Sept 2003 | - | $3.44 M(-1.2%) |
| June 2003 | - | $3.48 M(+23.8%) |
| Mar 2003 | - | $2.81 M |
| Dec 2002 | $12.02 M(+47.6%) | - |
| Dec 2001 | $8.15 M(+105.6%) | - |
| Dec 2000 | $3.96 M(+383.8%) | - |
| Dec 1999 | $819.00 K | - |
FAQ
- What is Oncternal Therapeutics annual total expenses?
- What is the all time high annual total expenses for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual total expenses year-on-year change?
- What is Oncternal Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly total expenses year-on-year change?
What is Oncternal Therapeutics annual total expenses?
The current annual total expenses of ONCT is $41.71 M
What is the all time high annual total expenses for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual total expenses is $68.01 M
What is Oncternal Therapeutics annual total expenses year-on-year change?
Over the past year, ONCT annual total expenses has changed by -$3.23 M (-7.19%)
What is Oncternal Therapeutics quarterly total expenses?
The current quarterly total expenses of ONCT is $8.68 M
What is the all time high quarterly total expenses for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly total expenses is $18.38 M
What is Oncternal Therapeutics quarterly total expenses year-on-year change?
Over the past year, ONCT quarterly total expenses has changed by -$1.71 M (-16.45%)